Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Genetic variation in the IL7RA/IL7 pathway increases multiple sclerosis susceptibility.
Data supporting the role of Fyn in initiating myelination in the peripheral nervous system.
Myelin-oligodendrocyte glycoprotein antibodies in adults with a neuromyelitis optica phenotype.
A case of multiple evanescent white dot syndrome misdiagnosed as optic neuritis: Differential diagnosis for the neurologist.
Emerging Concepts on the Gut Microbiome and Multiple Sclerosis.
Specific inhibition of secreted NRG1 types I-II by heparin enhances Schwann Cell myelination.
Predictors of long-term disability accrual in relapse-onset multiple sclerosis.
Interferon beta-1a therapy enhances CD4+ regulatory T-cell function: an ex vivo and in vitro longitudinal study in relapsing-remitting multiple sclerosis.
Are changes in gait and balance across the Disease Step Rating Scale in Multiple Sclerosis statistically significant and clinically meaningful?
Tizanidine: Can Buy Uk
Serial gadolinium enhanced magnetic resonance imaging in multiple sclerosis.
LKB1 and SAD kinases define a pathway required for the polarization of cortical neurons.
Will the real multiple sclerosis please stand up?
Relationship between neuromuscular and perceived fatigue and locomotor performance in patients with multiple sclerosis.
Clinical efficacy assessment in photodamaged skin of 0.5% and 1.0% idebenone.
The search for the target antigens of multiple sclerosis, part 1: autoreactive CD4+ T lymphocytes as pathogenic effectors and therapeutic targets.
FDA approves Genzyme’s AUBAGIO® (teriflunomide), a once-daily, oral treatment for relapsing multiple sclerosis
Biogen Idec and Abbott Announce Enrollment of First Patient in Global Phase III Study of Daclizumab for Relapse Remitting Multiple Sclerosis
Comparative miRNA-Based Fingerprinting Reveals Biological Differences in Human Olfactory Mucosa- and Bone-Marrow-Derived Mesenchymal Stromal Cells.
Effects of a 4-month Ananda Yoga Program on Physical and Mental Health Outcomes for Persons With Multiple Sclerosis.
Standing up in multiple sclerosis (SUMS): protocol for a multi-centre randomised controlled trial evaluating the clinical and cost effectiveness of a home-based self-management standing frame programme in people with progressive multiple sclerosis.
HLA alleles as biomarkers of high-titre neutralising antibodies to interferon-β therapy in multiple sclerosis.
Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis.
UCSF Seminar: "The needle in the haystack: Searching for target antigens of the adaptive immune response in MS."
Effector T cell interactions with meningeal vascular structures in nascent autoimmune CNS lesions.
Pages
« first
‹ previous
…
80
81
82
83
84
85
86
87
88
…
next ›
last »